Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HCM stock hub

HUTCHMED (China) Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HCMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.3B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

HCM

In the news

Latest news · HCM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E45.2

P25 12.3P50 18.4P75 33.1

Trailing P/E5

P25 14.9P50 23.2P75 38.5

ROE45.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-1,741.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HCM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

215

Groups with data

Currency

USD

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001648257
Company name	HUTCHMED (China) Limited
Country	Hong Kong
Country code	US
Cusip	44842L103
Employees	1,796
Employees Change	-15%
Employees Change Percent	-0.83
Enterprise value	$1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Isin	US44842L1035
Last refreshed	2026-05-10
Market cap	$2.3B
Market cap category	Mid-Cap
Price	$13.17
Price currency	USD
Rev Per Employee	305,407.57x
Sector	Healthcare
Sic	2834
Symbol	HCM
Website	https://www.hutch-med.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	20%
EV Earnings	2.21x
EV/Sales	1.84x
FCF yield	-3.45%
Forward P/E	45.19x
P/B ratio	1.83x
P/E ratio	5x
P/S ratio	4.16x
PE Ratio3 Y	18.71x
PE Ratio5 Y	37.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.14%
EBITDA Margin	-4.71%
Gross margin	11.64%
Gross Profit	$63.9M
Gross Profit Growth	-7.72%
Net Income	$456.9M
Net Income Growth	1,111.03%
Net Income Growth Q	-83.61%
Net Income Growth Years	1%
Pretax Margin	95.05%
Profit Margin	83.3%
Profit Per Employee	$254,404
Profitable Years	3
ROA	-1.62
Roa5y	-8.71
ROCE	-2.72
ROE	45.25
Roe5y	0.1
ROIC	-1,741.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.47%
Cagr1y	-9.8%
Cagr3y	-6.14%
Cagr5y	-12.87%
EPS Growth	1,200
EPS Growth Q	-98.06
EPS Growth Years	1
FCF Growth Q	-89.68%
OCF Growth Q	-79.58%
Revenue Growth	-12.96x
Revenue Growth Q	-16.54x
Revenue Growth Years	0x
Revenue Growth3 Y	8.76x
Revenue Growth5 Y	19.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.36
Assets	$1.8B
Cash	$1.4B
Current Assets	$1.6B
Current Liabilities	$315.8M
Debt	$97.9M
Debt Equity	$0.08
Equity	$1.3B
Interest Coverage	-13.67
Liabilities	$501.8M
Long Term Assets	$185.8M
Long Term Liabilities	$186.1M
Net Cash	$1.3B
Net Cash By Market Cap	$55.64
Net Cash Growth	58.31%
Net Debt Equity	$-1.02
Tangible Book Value	$1.2B
Tangible Book Value Per Share	$1.44
WACC	6.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.96
Inventory Turnover	10.59
Net Working Capital	$-89.5M
Quick ratio	4.81
Working Capital	$1.3B
Working Capital Turnover	$0.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.01%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-4.57%
1Y total return	-9.79%
200-day SMA	15.03
3Y total return	-17.33%
50-day SMA	14.27
50-day SMA vs 200-day SMA	50under200
5Y total return	-49.79%
All Time High	43.94
All Time High Change	-70.03%
All Time High Date	2021-07-29
All Time Low	7.39
All Time Low Change	78.21%
All Time Low Date	2022-10-24
ATR	0.41
Beta	0.38
Ch YTD	-1.2
High	13.44
High52	19.5
High52 Date	2025-07-29
High52ch	-32.46%
Low	13.17
Low52	12.82
Low52 Date	2026-05-01
Low52ch	2.73%
Ma50ch	-7.71%
Price vs 200-day SMA	-12.36%
RSI	33.31
RSI Monthly	43.72
RSI Weekly	41.4
Sharpe ratio	-0.18x
Sortino ratio	-0.11
Total Return	-0.01%
Tr YTD	-1.2
Tr1m	-14.42%
Tr1w	-0.98%
Tr3m	-13.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Sell
Earnings EPS Estimate	$1.43
Earnings EPS Estimate Growth	550
Earnings Revenue Estimate	591,424,624x
Earnings Revenue Estimate Growth	-6.15x
Operating Income	$-39.2M
Operating margin	-7.14
Price target	$13.75
Price Target Change	$4.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	508,428,282%
Float Percent	59.14%
Net Borrowing	6,258,000
Shares Insiders	0.98%
Shares Institutions	24.13%
Shares Out	859,744,319
Shares Qo Q	0.07%
Shares Yo Y	0.01%
Short Ratio	8.94
Short Shares	0.3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-94.1M
Average Volume	30,090.85x
Bv Per Share	1.44
CAPEX	$-14.1M
Ch10y	-4.57
Ch1m	-14.42
Ch1w	-0.98
Ch1y	-9.79
Ch3m	-13.24
Ch3y	-17.33
Ch5y	-49.79
Ch6m	-11.91
Change	-1.05%
Change From Open	-0.38
Close	13.31
Days Gap	-0.68
Depreciation Amortization	13,308,000
Dollar Volume	218,490.3
Earnings Date	2026-03-05
Earnings Time	bmo
EBIT	$-39.2M
EBITDA	$-25.9M
EPS	$0.52
F Score	3
FCF	$-78.8M
FCF EV Yield	-7.79x
FCF Per Share	$-0.09
Financing CF	7,836,000
Fiscal Year End	December
Founded	2,000
Goodwill	3,112,000
Graham Number	20.614
Graham Upside	57
Income Tax	$63.6M
Investing CF	-29,410,000
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-05
Ma150	14.57
Ma150ch	-9.58%
Ma20	14.17
Ma20ch	-7.05%
Net CF	-82,628,000
Next Earnings Date	2026-08-06
Open	13.22
Optionable	Yes
Position In Range	0
Post Close	13.17
Postmarket Change Percent	-0.3
Postmarket Price	$13.13
Ppne	97,650,000
Price Date	2026-05-08
Ptbv Ratio	1.85
Relative Volume	0.55x
Revenue	548,512,000x
SBC By Revenue	2.79x
Share Based Comp	15,292,000
Tax By Revenue	11.6x
Tax Rate	12.2%
Tr6m	-11.91%
Volume	16,590
Z Score	3.9

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HCM pay a dividend?

Capital-return profile for this ticker.

Performance

HCM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HCM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+24.1%

Float: +59.1% of shares outstanding

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

HCM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.3

Neutral momentum band

Price vs 200-day MA

-12.4%

50/200-day relationship not available

Beta (5Y)

0.38

Less volatile than the market

Sharpe ratio

-0.18

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HCM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current HCM stock rating?

HUTCHMED (China) Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full HCM analysis?

The full report lives at /stocks/HCM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for HCM?

The latest report frames HCM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the HCM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.